View More
Listen as expert faculty discusses the clinical impact of the most important NAFLD/NASH data from the Vienna meeting.
Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD
Released: May 2, 2019
Listen to expert commentary on the clinical impact of data from the Vienna meeting regarding treatment of viral hepatitis and progress toward HCV elimination.
Stefan Zeuzem, MD
Released: May 10, 2019
Expert faculty members summarize key studies on hepatitis C treatment and elimination, hepatitis B treatment, NASH/NAFLD clinical impact, and NASH treatment studies from this important annual conference.
Nancy Reau, MD
Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD
Stefan Zeuzem, MD
Released: April 30, 2019
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.